Quantcast

Latest Oncology Stories

2014-07-25 23:07:57

The Mesothelioma Victims Center is urging diagnosed victims of mesothelioma, or their family members, to call them at 866-714-6466 for a new service that includes a full explanation of the costs of treating mesothelioma for any victim who has recently been diagnosed with mesothelioma. The center would like to see all diagnosed victims receive the best possible compensation, and wants to make sure none are buried with enormous medical bills that may lead to bankruptcy....

2014-07-25 23:03:27

Brian Olson Discusses Diagnosis, Importance of Patient Resources and Support Chicago, IL (PRWEB) July 25, 2014 There are 700,000 people in the U.S. living with a brain tumor, and 500 diagnosed each day. Though when someone hears the words, “you have a brain tumor,” they often feel alone, confused and are unsure of the next step and where to turn. The American Brain Tumor Association (ABTA) is helping people figure out that next step by providing and pursuing the answers patients so...

2014-07-25 23:03:18

Harvard Neuro-Oncologist presents latest brain tumor research and treatment options at American Brain Tumor Association’s annual conference. Chicago, IL (PRWEB) July 25, 2014 Progress in understanding the molecular genetics of brain tumors has ushered in a new era of promising brain tumor treatments, according to Patrick Wen, MD, professor of neurology, Harvard Medical School, director of the Center for Neuro-Oncology, Dana-Farber Cancer Institute. At the American Brain Tumor...

2014-07-25 23:01:44

Researchers at the ECOG-ACRIN Cancer Research Group say comprehensive informed consent is likely the key to preventing undue anxiety over lung screenings. Philadelphia, PA (PRWEB) July 25, 2014 A new study of participants in the National Lung Screening Trial (NLST), the results of which are published today in Cancer, found evidence that men and women between the ages of 55 and 74 who had an abnormal finding on a lung cancer screening test did not experience more anxiety or reduced quality...

2014-07-25 10:41:50

Temple University Health System Asking patients if a suspicious skin lesion is painful or itchy may help doctors decide whether the spot is likely to be cancerous, according to a new study headed by Gil Yosipovitch, MD, Chairman of the Department of Dermatology at Temple University School of Medicine. The study, published online by JAMA Dermatology on July 23, 2014, found that nearly 36. 9 percent of skin cancer lesions are accompanied by itching, while 28.2 percent involve pain....

2014-07-25 08:26:13

SUNNYVALE, Calif., July 25, 2014 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending the granting of full marketing approval for IMBRUVICA(®) (ibrutinib) in the European Union. IMBRUVICA is being jointly developed and commercialized in the United States by Pharmacyclics and Janssen Biotech, Inc. In Europe, once approved,...

2014-07-25 08:25:15

Phase I studies start in 2015 NEW HAVEN, Conn., July 25, 2014 /PRNewswire/ -- Oncology drug developer, CanTx Inc., and its parent company, Novogen Ltd. (ASX; NRT: NASDAQ; NVGN), today announced that they have named two key contract manufacturing organizations (CMOs) to produce clinical batches of the experimental anti-cancer drug, Cantrixil(TM). CanTx and Novogen expect to file an Investigational New Drug (IND) application for Cantrixil early next year and to advance this compound...

2014-07-25 08:24:56

LUGANO, Switzerland, July 25, 2014 /PRNewswire/ -- The European Society for Medical Oncology (ESMO) has expressed concern that the proposed EU General Data Protection Regulation could make cancer research impossible and add a significant burden to cancer patients and doctors. (Logo: http://photos.prnewswire.com/prnh/20131128/654773 ) The proposed wording -'explicit and specific patient consent' - implies that researchers would have to approach patients and ask...

2014-07-24 23:05:03

The first-ever successful isolation and culture of rare tumor cells circulating in a patient’s blood has been achieved by NFCR-supported scientist Daniel Haber, M.D., Ph.D., and his team at Massachusetts General Hospital. Bethesda, MD (PRWEB) July 24, 2014 The first-ever successful isolation and culture of rare tumor cells circulating in a patient’s blood has been achieved by NFCR-supported scientist Daniel Haber, M.D., Ph.D., and his team at Massachusetts General Hospital. This is an...

2014-07-24 08:34:35

WASHINGTON, July 24, 2014 /PRNewswire/ -- The Mesothelioma Compensation Center knows that many diagnosed victims of mesothelioma, or their family members discount the compensation possibilities because of the age of the victim, and as they would like to explain with one call to 866-714-6466 this can be a gigantic mistake for the victim, or their family members. According to the CDC the average of a diagnosed victim of mesothelioma is 72 years old. http://MesotheliomaCompensationCenter.Com...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related